OREGON HEALTH & SCIENCE UNIVERSITY;OREGON HEALTH & SCIENCES UNIVERSITY
发明人:
申请号：
IL25927118
公开号：
IL259271D0
申请日:
2018.05.10
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
Diagnostic methods for identifying cancer bearing subjects appropriate for treatment with CPX-351 include genetic and ex vivo testing of cells from a candidate subject. Combination treatment with CPX-351 and FLT-3 inhibitors improve CPX-351 uptake and toxicity.
